Open access peer-reviewed chapter

Glucose Tolerance Factor – Insulin Mimetic and Potentiating Agent – A Source for a Novel Anti Diabetic Medication

By Nitsa Mirsky

Submitted: December 22nd 2011Reviewed: October 15th 2012Published: December 12th 2012

DOI: 10.5772/54350

Downloaded: 2034

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Nitsa Mirsky (December 12th 2012). Glucose Tolerance Factor – Insulin Mimetic and Potentiating Agent – A Source for a Novel Anti Diabetic Medication, Glucose Tolerance, Sureka Chackrewarthy, IntechOpen, DOI: 10.5772/54350. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/glucose-tolerance/glucose-tolerance-factor-insulin-mimetic-and-potentiating-agent-a-source-for-a-novel-anti-diabetic-m" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

2034total chapter downloads

1Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Medicinal Plants and Natural Compounds from the Genus Morus (Moraceae) with Hypoglycemic Activity: A Review

By Jackson Roberto Guedes da Silva Almeida, Grasielly Rocha Souza, Edigênia Cavalcante da Cruz Araújo, Fabrício Souza Silva, Julianeli Tolentino de Lima, Luciano Augusto de Araújo Ribeiro, Xirley Pereira Nunes, José Maria Barbosa Filho, Lucindo José Quintans Júnior and Márcio Roberto Viana dos Santos

Related Book

First chapter

Overview About Lipid Structure

By Rodrigo Valenzuela B. and Alfonso Valenzuela B.

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us